Cell Source, Inc. Business Finance Contracts & Agreements

62 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Purchase Agreement between Cell Source, Inc. and Multiple Canadian Investment ULCs (August 20, 2024)
Purchase Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 2 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 3 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Helen Samuel Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Honey Kamenetsky Investment ULC (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Phyllis Friedman Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Solomon Zolty Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with David Zolty Investment ULC (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Darlene Soave Revocable Trust (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Amendment No. 1 to 10% Convertible Note between Cell Source, Inc. and Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 3 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 2 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 1 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Cell Source, Inc. 10.0% Convertible Note Agreement with George Verstraete dated March 9, 2022
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2022
Amendment No. 2 to Sponsored Research Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2022
Description of Common Stock of Cell Source, Inc.
Stock Agreements
Cell Source, Inc.
Biotechnology
2022
Cell Source, Inc. Third Amended and Restated 10.0% Convertible Note with Darlene D. Soave
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Second Amended and Restated 10.0% Convertible Note between Cell Source, Inc. and Darlene D. Soave
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Cell Source, Inc. 8.0% Convertible Note Agreement with Lender (October 2020)
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Cell Source, Inc. 10% OID Convertible Promissory Note Due January 29, 2021
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Securities Purchase Agreement between Cell Source, Inc. and Purchasers (July 29, 2020)
Purchase Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Convertible Promissory Note between Cell Source, Inc. and Power Up Lending Group Ltd. dated January 10, 2020
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. 8.0% Convertible Note Agreement with Darlene D. Soave (October 2019)
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Amendment No. 1 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2019
Promissory Note between Cell Source, Inc. and Main Street Restaurant Associates Inc. dated May 10, 2016
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. $250,000 Convertible Note Due July 27, 2016 with Prodigious Wealth Limited
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Promissory Note and Subscription Agreement (March 8, 2016)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Warrant to Purchase Common Stock Agreement with Darlene Soave
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2021
Note Exchange Agreement between Cell Source, Inc. and [Holder] Dated February 4, 2021
Exchange Agreements
Cell Source, Inc.
Biotechnology
NV
2021
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. 2019 Israeli Equity Incentive Sub-Plan Stock Option Agreement (October 2020)
Warrant Agreements
Cell Source, Inc.
Biotechnology
2020
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Participant
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2020
Cell Source, Inc. Warrant to Purchase 200,000 Shares of Common Stock (Advisory Agreement Related)
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Common Stock Purchase Warrant Agreement between Cell Source, Inc. and Purchaser (July 29, 2020)
Warrant Agreements
Cell Source, Inc.
Biotechnology
2020
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Yair Reisner
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2019
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Yair Reisner
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2019
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2018
Cell Source, Inc. Warrant to Purchase 150,000 Shares of Common Stock
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2016